Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC)

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/34987

Title:	Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC)
Authors:	UNTCH, M.; GEYER JR., C. E.; HUANG, C.; LOIBL, S.; WOLMARK, N.; MANO, M. S.; MINCKWITZ, G. von; BRUFSKY, A.; PIVOT, X.; POLIKOFF, J.; FONTANA, A.; KAUFMAN, B.; ALCEDO, J. C.; BOULET, T.; LIU, H.; SONG, C.; MAMOUNAS, E. P.
Citation:	ANNALS OF ONCOLOGY, v.30, suppl.9, 2019
Appears in Collections:	Comunicações em Eventos - FM/Outros Outros departamentos - FM/Outros

Files in This Item:

There are no files associated with this item.